Prevalence of Irritable Bowel Syndrome in Japan, China, and South Korea: An International Cross-sectional Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Background/Aims: Symptoms of irritable bowel syndrome (IBS), a common gut-brain interaction disorder, deteriorate patients' quality of life and increase medical needs; therefore, IBS represents a significant global burden. The estimated global prevalence is approximately 10%; however, accumulated evidence shows international heterogeneity. In this study, we have described and compared the prevalence of IBS in 3 East Asian countries: Japan (Tokyo and Fukuoka), China (Beijing), and South Korea (Seoul). Methods: We conducted an internet-based cross-sectional survey of the urban population aged > 20 years in the abovementioned countries. We recruited equal numbers of age- (20s-60s) and sex-matched participants (3910 residents). IBS was diagnosed according to the Rome III criteria, and the subtypes were analyzed. Results: < 0.001). Furthermore, 54.9% of patients were male. IBS-mixed was the most prevalent subtype; the prevalence of other subtypes varied. Conclusions: The overall prevalence of IBS in the 3 countries was slightly higher than the global prevalence, and it was significantly lower in China than in Japan and South Korea. IBS prevalence was the highest and lowest among individuals in their 40s and 60s, respectively. Male individuals had a higher prevalence of IBS with diarrhea. Further studies are needed to elucidate the factors associated with this regional heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disruption of the microbiota balance can lead to a reduction in some metabolites and slowed intestinal peristalsis, resulting in the accumulation of indigestible oligosaccharides in the large intestine, which in turn causes symptoms, such as abdominal pain, bloating, and constipation [2].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functional gastrointestinal disorders and the Rome III process
Drossman, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.008 · Cited by 2,416
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.04.014 · Cited by 2,263
Self-citationGlobal Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Composition, variability, and temporal stability of the intestinal microbiota of the elderly
Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J. R., Falush, D., Dinan, T., Fitzgerald, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000097107 · Cited by 1,754
Oka, P., Parr, H., Barberio, B., Black, C. J., Savarino, E. V., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30217-x · Cited by 882 · cited 6×
“4% in China (South Korean data were not shown).(8) IBS prevalence is reported to be higher in young and female individuals.”
InfluentialThe impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“Irritable bowel syndrome (IBS) is a symptom complex involving abdominal pain, bloating, diarrhea, and constipation, and leads to a substantial reduction in quality of life.(1) Although IBS is not lifethreatening, it has significant socioeconomic consequences.”
BackgroundSperber, A. D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U. C., Gwee, K. A., Hungin, A. P. S., Kang, J.-Y., Minhu, C., Schmulson, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311240 · Cited by 554 · cited 4×
“%) in the Middle East and Africa.4 In Asian countries, IBS prevalence ranges from 1.1% in Iran to 21.2% in Japan.”
BackgroundResultInfluentialSelf-citationPalsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.021 · Cited by 461 · cited 1×
“In previous large-scale international population-based studies and meta-analyses, IBS prevalence was reported to be lower in individuals aged 50 years or older than in those younger than 50 years.(4,20,21) This finding is consistent with our results.”
ResultLovell, R. M., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.131 · Cited by 412
Costs of Irritable Bowel Syndrome in the UK and US
Maxion-Bergemann, S., Thielecke, F., Abel, F., & Bergemann, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00002 · Cited by 263
Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem
Frändemark, Å., Törnblom, H., Jakobsson, S., & Simrén, M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0262-x · Cited by 209 · cited 1×
“Work-ability impairment is another substantial concern; as IBS symptom severity increases, the degree of work-ability impairment also increases.(3) Thus, IBS poses a considerable burden on both healthcare services and society.”
BackgroundEvidence-based clinical practice guidelines for irritable bowel syndrome
Fukudo, S., Kaneko, H., Akiho, H., Inamori, M., Endo, Y., Okumura, T., Kanazawa, M., Kamiya, T., Sato, K., Chiba, T., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-1017-0 · Cited by 205
Self-citationWANG, A., LIAO, X., XIONG, L., PENG, S., XIAO, Y., LIU, S., HU, P., & CHEN, M. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-43 · Cited by 143
Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study
LEE, S., WU, J., MA, Y. L., TSANG, A., GUO, W. ‐., & SUNG, J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04074.x · Cited by 136
Second Asian Consensus on Irritable Bowel Syndrome
Gwee, K. A., Gonlachanvit, S., Ghoshal, U. C., Chua, A. S. B., Miwa, H., Wu, J., Bak, Y.-T., Lee, O. Y., Lu, C.-L., Park, H., et al. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19041 · Cited by 112
Self-citationIrritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management
Gwee, K., Ghoshal, U. C., & Chen, M. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13987 · Cited by 98
Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea
Park, J. M., Choi, M.-G., Cho, Y. K., Lee, I. S., Kim, J. I., Kim, S. W., & Chung, I.-S. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.3.279 · Cited by 95
Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria.
Miwa, H. (2008) · PubMed Central · Cited by 94
Park, D. W., Lee, O. Y., Shim, S. G., Jun, D. W., Lee, K. N., Kim, H. Y., Lee, H. L., Yoon, B. C., & Choi, H. S. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.2.186 · Cited by 77
Matsumoto, S., Hashizume, K., Wada, N., Hori, J., Tamaki, G., Kita, M., Iwata, T., & Kakizaki, H. (2013) · BJU International · doi:10.1111/j.1464-410x.2012.11591.x · Cited by 63
Cultural Factors Influencing Functional Gastrointestinal Disorders in the East
Chuah, K.-H., & Mahadeva, S. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18064 · Cited by 63
Olafsdottir, L. B., Gudjonsson, H., Jonsdottir, H. H., & Thjodleifsson, B. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04388.x · Cited by 62
Consumption of spicy foods and the prevalence of irritable bowel syndrome
Esmaillzadeh, A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i38.6465 · Cited by 61
Kanazawa, M., Miwa, H., Nakagawa, A., Kosako, M., Akiho, H., & Fukudo, S. (2016) · BioPsychoSocial Medicine · doi:10.1186/s13030-016-0070-8 · Cited by 58
Self-citationKanazawa, M., Nakajima, S., Oshima, T., Whitehead, W. E., Sperber, A. D., Palsson, O. S., Drossman, D. A., Miwa, H., & Fukudo, S. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15016 · Cited by 45
Self-citationIrritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management
Liu, Y.-L., & Liu, J.-S. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001550 · Cited by 44
Sperber, A. D., Friger, M. D., Shvartzman, P., Abu-Rabia, M., Abu-Rabia, R., Abu-Rashid, M., Albedour, K., Alkranawi, O., Eisenberg, A., Kazanoviz, A., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00553-1 · Cited by 37
Zhang, L., Duan, L., Liu, Y., Leng, Y., Zhang, H., Liu, Z., & Wang, K. (2014) · PubMed · Cited by 30
Kosako, M., Akiho, H., Miwa, H., Kanazawa, M., & Fukudo, S. (2018) · BioPsychoSocial Medicine · doi:10.1186/s13030-018-0131-2 · Cited by 29
Self-citationPrevalence of irritable bowel syndrome in Italian rural and urban areas
Usai, P., Manca, R., Lai, M. A., Russo, L., Boi, M. F., Ibba, I., Giolitto, G., & Cuomo, R. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.05.009 · Cited by 25
Kamiya, T., Osaga, S., Kubota, E., Fukudo, S., Motoya, S., Murakami, K., Nagahara, A., Shiotani, A., Sugimoto, M., Suzuki, H., et al. (2020) · Digestion · doi:10.1159/000513292 · Cited by 24
Self-citationSurvey of Clinical Practice for Irritable Bowel Syndrome in East Asian Countries
Fukudo, S., Hahm, K., Zhu, Q., Sollano, J. D., Rani, A. A., Syam, A. F., Kachintorn, U., Suzuki, H., Kamiya, T., Joh, T., et al. (2015) · Digestion · doi:10.1159/000369078 · Cited by 19
Self-citationWhat impact do Rome IV criteria have on patients with IBS in China?
Wang, B., Zhao, W., Zhao, C., Jin, H., Zhang, L., Chen, Q., & Wang, B. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1698650 · Cited by 12
Cited by
Arif, T. B., Ali, S. H., Bhojwani, K. D., Sadiq, M., Siddiqui, A. A., Ur-Rahman, A., Khan, M. Z., Hasan, F., & Shahzil, M. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002994 · Cited by 50
Liu, J., Lv, C., Yin, M., Zhu, M., Wang, B., Tian, J., Hashimoto, K., & Yu, Y. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003257 · Cited by 59
Chronic constipation and gut microbiota: current research insights and therapeutic implications
Xu, X., Wang, Y., Long, Y., & Cheng, Y. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae112 · Cited by 32
Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome
Zhang, H., & Su, Q. (2025) · Nutrients · doi:10.3390/nu17030544 · Cited by 33
Yang, D., Lyu, C., He, K., Pang, K., Guo, Z., & Wu, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031544 · Cited by 22
Metadata
- Authors
- Takeoka, A., Kimura, T., Hara, S., Hamaguchi, T., Fukudo, S., & Tayama, J.
- Affiliations
- Nagasaki University (JP)
- Kyushu University (JP)
- Kyoto Tachibana University (JP)
- Saitama Prefectural University (JP)
- Tohoku University (JP)
- Waseda University (JP)
- Corresponding author
- Tayama, Jun
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2023-04-30
- Volume
- 29
- Issue
- 2
- Pages
- 229-237
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- PMC
- PMC10083109
- OpenAlex
- W4362638032
- Cited by
- 30
- References
- 33
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 11 · 2023: 2
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Locations
- Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (27819)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, prevalence, IBS subtypes, Rome III criteria, gut-brain axis, regional variation, East Asia, Japan, China, South Korea, sex differences, age differences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
